Following a gift from Brown trustee Giammaria Giuliani P’28 and Sabrina Giuliani P’28, Brown’s RNA center will be named the ...
14hon MSNOpinion
Pfizer is said to divest remaining stake in BioNTech
BioNTech (BNTX) stock slips as Pfizer (PFE) plans to sell its remaining stake in the COVID-19 vaccine developer in a ...
9hon MSN
Lifelong drugs for autoimmune diseases don’t work well. Now scientists are trying something new
There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...
TipRanks on MSN
Moderna Approves Stock Option Exchange Program
The first was a one-time stock option exchange program for non-Executive Committee employees, which received significant support from stockholders. The second proposal allowed for the adjournment of ...
Key opportunities in the RNA targeting small molecules therapeutics market include growth in RNA splicing modifications, neurodegenerative diseases, drug discovery, and pharma-biotech sectors.
Investor's Business Daily on MSN
Korro Bio Plummets To A Record Low On A Big Setback In RNA-Editing
Korro BioKRRO stock plummeted Thursday after its RNA-editing drug failed to pass muster in patients with a rare lung and ...
In a leap for biomedical science, researchers from the A*STAR Genome Institute of Singapore (A*STAR GIS) and A*STAR Bioinformatics Institute (A*STAR BII), in collaboration with the University of ...
Biovac starts first oral cholera vaccine trial in 50 years amid Africa surge Africa accounts for 82% of global cholera cases; vaccine stockpiles strained New Cape Town lab backs AU goal to produce 60% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback